Results from the CLEAR IVH SAFETY trial have been published in the November 2011 issue of Stroke. This publication showed that low-dose rtPA for the treatment of intracerebral hemorrhage with intraventricular hemorrhage has an acceptable safety profile compared to placebo and historical controls.
This was the first clinical trial demonstrating the safety of rtPA for treatment of IVH and is the basis for our current phase three trial (CLEAR III). Click CONTINUE READING for the downloadable publication.
We are also thrilled to share with you the editorial accompanying this article, "CLEAR Intraventricular Hemorrhage : More Than a Glimmer of Hope."
Additional articles and publications regarding CLEAR III are in the download archives under the Publications tab.